You are here:

Oncology

Beyond KRAS exon 2: Research at ASCO and Important Treatment Implications for Metastatic Colorectal Cancer

16 Jul 2014, by Stephanie Hawthorne

New biomarker data in metastatic colorectal cancer (mCRC) presented at ASCO 2014 showed clinical implications of RAS mutations. The influence of RAS mutations on testing and treatment patterns of mCRC has profound implications on a tumor’s behavior throughout the course of the disease.

READ

Market Access

The Evolving Use of White Bagging in Oncology

28 Mar 2014, by Gordon Gochenauer

Channel dynamics are changing for physician-administered infusible drugs, with implications for practice economics, payer utilization management, site of care, and availability of data for manufacturers. Today, buy and bill’ is the primary method of distribution of IV oncology drugs, whereby oncology practices typically purchase these drugs from specialty distributors/group purchasing organizations (GPOs), which are then billed to payers under the medical benefit.

READ

Emerging Markets

Empowering Children to Become Community Leaders

29 May 2014, by Lynnette Cooke

Transforming a community’s culture takes time and patience, especially when the community is spread out over many miles of rough terrain. But all you need are a few champions to create some momentum.

READ

Additional marketing insights & consultancy

A roadmap for brand marketing success

16 Jul 2014, by Mark Sales

Whether you are six or 12 months from launch – or even just starting the launch phase – it would be useful to check that you are where you need to be in terms of the crucial factors we believe are the new core components of brand marketing.

READ